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Null mutation of the Foxg1 gene causes hypoplasia of the mouse telencephalon and loss of ventral telencephalic structures. We show that
a crucial early requirement for Foxg1 is in the induction of ventral cell fate in the telencephalon. To study later proliferative defects, we have
adapted an iododeoxyuridine and bromodeoxyuridine double labeling protocol for use in the developing embryo, which allows estimation of
cell cycle kinetics in a single specimen. This technique is used to demonstrate that the cell cycle is prematurely lengthened in the Foxg1-null
telencephalon. These defects are first apparent at embryonic day 10.5 (E10.5) and are most severe in the rostral telencephalon. We show that
apoptosis is also reduced in the same rostral domain. These defects correspond temporally and spatially with a dramatic reduction in
expression of the potent signaling molecule Fgf 8. We also show that in the absence of Foxg1 an excess of neurons is produced from E11.5,
depleting the progenitor pool and limiting the growth of the Foxg1/ telencephalon. The increase in neurogenic division coincides with an
increase in BMP signaling, as detected by immunohistochemistry for phosphorylated smad-1, -5, and -8. This study reinforces Foxg1’s
position as a major regulator of telencephalic neurogenesis and supports the idea that Foxg1 controls precursor proliferation via regulation of
Fgf signaling and differentiation via regulation of Bmp signaling.
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The embryonic telencephalon arises from the most rostral
region of the neural tube, later giving rise to the adult
cerebral cortex, hippocampus, olfactory bulbs, and basal
ganglia. Soon after its specification, the telencephalon
undergoes a period of rapid expansion where the progeny
of every cell division re-enters the cell cycle (Bhide, 1996;
Caviness et al., 1995). Following this period, there is a
gradual slowing of the rate of growth as the progenitor cell
cycle lengthens and an increasing proportion of newly born
cells exit the cell cycle to differentiate into neurons (Sheth0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.04.005
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E-mail address: john.mason@ed.ac.uk (J.O. Mason).and Bhide, 1997; Takahashi et al., 1996). During this period
of telencephalic neurogenesis, the vast majority of neurons
that will populate the adult brain for the lifetime of the
animal are produced. In order to ensure that the correct types
of neurons are produced in the right numbers at the right
time and place, the behavior of the telencephalic progenitor
cells must be accurately choreographed. Three factors have
a major influence on the cellular output from the prolifer-
ative zones: the rate of cell proliferation, the rate of cell
differentiation, and the rate of cell death. Any failure to
correctly regulate any of these crucial processes may have a
profound effect on the number of cells produced and the
structure of the brain region concerned. Understanding how
these processes are modulated at a genetic level remains a
major challenge.283 (2005) 113 – 127
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controlling the process of neurogenesis is the winged helix
transcription factor Foxg1 (previously known as BF-1) (Tao
and Lai, 1992). Analysis of transgenic mice which lack
Foxg1 provided early evidence that the gene is a key
regulator of neurogenesis (Xuan et al., 1995). At embryonic
day 9.5 (E9.5), the telencephalon of Foxg1/ embryos
appears grossly similar to that of wild-types. However, from
E10.5 until their perinatal death, the telencephalon of Foxg1-
null mice is noticeably reduced in size. Based on bromo-
deoxyuridine (BrdU) labeling studies and immunohisto-
chemical staining for markers of differentiated neurons,
previous authors have suggested that the causes of the
observed telencephalic hypoplasia are 2-fold: reduced
progenitor cell proliferation and an increased rate of diffe-
rentiation (Hanashima et al., 2002; Xuan et al., 1995). These
observations point to Foxg1 being an important regulator of
the timing and mode of neurogenesis in the telencephalon.
Here we demonstrate a powerful approach to measuring
the cell cycle kinetics of telencephalic neural progenitor cells.
Using this technique, we have characterized in detail the
proliferation rate of these cells throughout the developing
telencephalon in wild-type and Foxg1/ embryos. As
neurogenesis begins (¨E10.5), rostrally positioned cells
begin to proliferate more slowly in the absence of Foxg1.
This slowing becomes more widespread and severe as
development proceeds, coinciding with an increased rate of
telencephalic neurogenesis. We also demonstrate that the
level of apoptosis is reduced in the rostral telencephalon of
Foxg1 mutants. Early proliferative and apoptotic defects are
shown to coincide with a reduction in the rostral expression of
Fibroblast growth factor 8 (Fgf8), thus providing a potential
mechanism for the aberrations of the neurogenetic process
described here. In addition to characterizing the role of Foxg1
in regulating growth and neurogenesis in the dorsal telen-
cephalon, we show that markers of ventral telencephalic cell
fate are never expressed in the Foxg1/ telencephalon,
suggesting that this transcription factor is required for the
induction of ventral fates in the telencephalon.Materials and methods
Animals
Foxg1cre and Foxg1lacZ animals were maintained on a
mixed CBA  C57-Bl6 background. In both of these alleles,
all but the first 13 amino acids of the Foxg1 coding sequence
is replaced by cre recombinase (Hebert and McConnell,
2000) or lacZ reporter (Xuan et al., 1995) coding sequences.
Foxg1-null embryos were obtained from timed matings of
Foxg1 heterozygous mice. Foxg1cre/cre, Foxg1lacz/lacz, and
Foxg1cre/lacz embryos were all observed to have the same
phenotypic abnormalities, in agreement with previous
authors (Hebert and McConnell, 2000; Pratt et al., 2002),
and are denoted Foxg1/. In all analyses, Foxg1 hetero-zygous embryos were found to be phenotypically identical to
wild-type as previously described (Pratt et al., 2002; Xuan et
al., 1995) and in some cases were included in the control
group. The day of the vaginal plug following mating was
designated E0.5. Embryonic and adult tissues were geno-
typed by PCR as described before (Pratt et al., 2004).
Injection of S-phase tracers
For double labeling experiments, pregnant females were
injected intra-peritoneally with 200 Al of 100 Ag/ml (in 0.9%
NaCl) iododeoxyuridine (IddU) (Sigma) and then 1.5 h later
with the same dose of bromodeoxyuridine (BrdU) (Sigma)
and sacrificed after 30 min. For 8 h BrdU cumulative
labeling, four BrdU injections were given at 0, 2, 4, and 6 h
before sacrifice at 8 h.
Calculation of cell cycle kinetic parameters
In the telencephalic neuroepithelium, precursors pro-
gress through the cell cycle asynchronously (Takahashi et
al., 1993). In such a population of proliferating cells, the
fraction of cells in a given phase of the cell cycle is
directly proportional to the length of that phase relative to
the total length of the cell cycle (Nowakowski et al.,
1989). BrdU and IddU are halogenated thymidine ana-
logues that are incorporated into DNA synthesized during
S-phase. Sequentially exposing proliferating cells to IddU
and BrdU allows us to differentiate between defined
populations of cells. The relative sizes of these populations
allow us to calculate the total cell cycle time (Tc) and the
length of S-phase (Ts) of the proliferating pool. According
to this technique, telencephalic progenitors are exposed to
IddU in vivo at T = 0 h such that all cells in S-phase at the
beginning of the experiment are labeled with IddU (Fig.
1A). At T = 1.5 h, cells are exposed to BrdU to label all
cells in S-phase at the end of the experiment (Scells) (Fig.
1A). These cells will also be labeled with IddU, which is
still present in the bloodstream. Animals are killed at T = 2
h. It takes approximately 30 min for injected IddU and
BrdU to circulate and label the DNA of S-phase cells to
detectable levels (Nowakowski et al., 1989); therefore, the
interval during which cells can incorporate IddU but not
BrdU (Ti) is 1.5 h (Fig. 1A). Since telencephalic neural
precursors are not synchronized, cells in the initial IddU-
labeled S-phase cohort will leave S-phase at a constant rate
during Ti. Consequently, this leaving fraction (Lcells) will
be labeled with IddU but not BrdU, as summarized in Fig.
1A. By staining tissue sections with monoclonal antibodies
that allow us to distinguish cells labeled with just IddU
from those which incorporated BrdU and IddU, we can
count the Lcells and Scells fractions (see Figs. 1B and C).
The ratio of the length of any one period of the cell cycle
to that of another period is equal to the ratio of the number
of cells in the first period to the number in the second
period (Nowakowski et al., 1989). Therefore, the ratio
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fractions is equal to the ratio between Ti (which equals
1.5 h) and Ts (Shibui et al., 1989):
Ti=Ts ¼ Lcells=Scells Ts ¼ Ti= Lcells=Scellsð Þ
where Lcells ¼ IddUþ=BrdU and Scells¼ IddUþ=BrdUþð Þ
By exactly the same logic, the calculated Ts can be used
to estimate Tc:
Ts=Tc ¼ Scells=Pcells Tc ¼ Ts= Scells=Pcellsð Þ
Pcells is the total number of proliferating cells in the
sampling area. In this case, Pcells is estimated by countingthe total number of cells in the ventricular zone (VZ) in the
sampling area. This equation, therefore, rests on the
assumption that all cells in the ventricular zone are
proliferating. Previous authors have shown that 98–100%
of cells in the VZ of the wild-type telencephalon are
indeed actively proliferating (Caviness et al., 1995;
Estivill-Torrus et al., 2002; Takahashi et al., 1993, 1995).
Here, 8 h cumulative BrdU labeling at E10.5 (Figs. 1D and
E) and proliferating cell nuclear antigen (PCNA) staining
at each age (Supplementary Fig. 1 and data not shown) in
Foxg1/ mutant and wild-type brains labeled all VZ cells
show that they are all proliferating. This technique also
assumes that the precursor cells consist of a single
proliferating population with the same cycling kinetics.
Evidence suggests this is indeed the case during early
telencephalic development. However, around E13.5 in the
dorsal telencephalon (Takahashi et al., 1995b) and E11.5 in
the ventral telencephalon (Sheth and Bhide, 1997), a
second proliferative population arises within the germinal
zone. Since the cell cycle kinetics of these populations are
very similar to those of the primary proliferative population
(Sheth and Bhide, 1997; Takahashi et al., 1995b), this
aspect of telencephalic development should not affect
results generated by this technique.
For the calculation of BrdU labeling index in the
ventralmost telencephalon, the number of BrdU-labeled
cells in two 100-Am sampling bins spaced 100 Am apart in
the ventralmost region of the telencephalon was counted and
expressed as a percentage of all VZ cells. A total of 14
counts were made in each of three control and Foxg1/
embryos in sections spaced evenly through the rostrocaudal
axis of the telencephalon.Fig. 1. Calculation of cell cycle kinetics by IddU/BrdU double labeling. (A)
To estimate cell cycle kinetic parameters, the pregnant mouse is injected
with IddU at T = 0 h to label all cells in S-phase at the beginning of the
experiment. At T = 1.5 h, an injection of BrdU is given and the embryos are
fixed after a short survival period of 0.5 h, sufficient to label the S-fraction
(Scells) at the end of the labeling period (Nowakowski et al., 1989). During
the 1.5 h interval when cells are exposed to IddU but not BrdU (Ti), some of
the initial S-phase cohort will leave S-phase and consequently will be
labeled just with IddU; this is the leaving fraction (Lcells). (B and C)
Monoclonal antibodies specific for both BrdU and IddU (green), and BrdU
alone (red), can then be used to identify cells in the S-fraction (red and
green double-labeled cells in B marked with yellow spots in C) and cells in
the L-fraction (green only in B and C, marked with red spots in C); blue
spots in C mark unlabelled cells. (D and E) At the beginning of
telencephalic neurogenesis (¨E10.5), essentially all VZ cells are actively
proliferating in both wild-type and Foxg1/ telencephalon, since they all
become labeled with BrdU following 8 h cumulative labeling at E10.5.
Therefore, a nuclear counterstain can be used to count all VZ cells which
represent the Pcells fraction (all stained nuclei in B and yellow, red, and light
blue marked nuclei in C). The Lcells, Scells, and Pcells fractions can then be
used to calculate Tc and Ts (see Materials and methods). (F) When Tc
estimates obtained in wild-types with this technique at a range of ages are
plotted against those obtained using BrdU cumulative labeling for matched
ages in the same tissues (Bhide, 1996; Estivill-Torrus et al., 2002;
Takahashi et al., 1996; Yuasa et al., 2002), there is a significant correlation
(P = 0.022, Pearson correlation test, n = 9), as shown by the linear
regression (gradient = 0.97, r = 0.73).
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Embryos were dissected in cold phosphate-buffered
saline (PBS) and then transferred to cold 4% paraformal-
dehyde in PBS and fixed with agitation for 3–5 h. They
were then dehydrated and embedded in paraffin wax
before sectioning in the coronal plane at 8–10 Am and
mounting on poly-l-lysine (Sigma)-coated slides. Sections
were dewaxed in xylene then rehydrated through graded
ethanol solutions to PBS. To denature DNA and reveal
antigens, the slides were boiled in 10 mM sodium citrate
(pH 6) in a microwave oven. After blocking in 10% nor-
mal goat serum (NGS) in PBS with 0.1% Triton X-100
(Sigma), sections were incubated overnight at 4-C with the
primary antibodies.
For IddU/BrdU double labeling, primary antibodies used
were mouse anti-BrdU/IddU (which recognizes both BrdU
and IddU) (clone B44, 1:100 in blocking solution; Becton
Dickinson) and rat anti-BrdU (clone BU1/75, 1:100;
Abcam). These primary antibodies were visualized with
highly cross-absorbed goat anti-mouse IgG conjugated to
Alexa488 (Molecular Probes A11029, 1:200) and goat anti-
rat Alexa568 (Molecular Probes A11077, 1:200), respec-
tively, in blocking solution for 1 h at room temperature in
the dark. Nuclei were counterstained with TO-PRO-3 iodide
(Molecular Probes) and mounted with Vectashield Hardset
(Vectorlabs). Appropriate controls were performed to ensure
that primary antibodies were indeed specific for the
halogenated pyrimidines and that there was no cross
reactivity of secondary antibodies.
To study regionalization of the telencephalon antibodies
to Pax3 (Developmental Studies Hybridoma Bank (DSHB),
1:400), Pax6 (DSHB, 1:400), Gsh2 (Toresson et al., 2000)
(1:1500), Mash1 (BD Pharmingen, 1:100), pan-Dlx (Hevner
et al., 2004) (1:100), and Nkx2.1 (Biopat, 1:1000); and
phosphorylated Smad 1,5,8 (Cell Signalling Technology,
1:100) were used with appropriate biotinylated secondary
antibodies (Dako, 1:200) followed by avidin-biotin-HRP
complex (Vector) and visualization with diaminobenzidine
(Vector). For the proliferation and differentiation analyses,
mouse monoclonal antibodies to h-III-Tubulin (TuJ1)
(Sigma, 1:1000) or proliferating cell nuclear antigen
(PCNA) (Dako, 1:200) were used with an Alexa488-
conjugated secondary antibody.
Enumeration of BrdU and IddU-labeled nuclei
Images were obtained with a TCS NT confocal micro-
scope (Leica Microsystems) with the 40 objective. Evenly
spaced sections throughout both the antero-posterior and
dorso-ventral dimensions of the embryonic telencephalon
were photographed (see Fig. 4A). For each section
analyzed, images were acquired in three channels (appea-
ring red, green, and blue in all figures) as separate files.
These images were then stacked with Photoshop software
(Adobe) and used for the enumeration of labeled cells.Data analysis and graph plotting
Data were analyzed and graphs plotted with the follow-
ing computer applications: with Excel (Microsoft), Sigma-
plot (Systat Software Inc.), and SPSS (SPSS software).
LacZ histochemistry
E12.5 Foxg1lacZ/+and Foxg1lacZ/lacZ embryonic heads
were dissected and fixed for 1 h at 4-C in 4% paraformal-
dehyde, 0.02% NP40, 0.01% sodium deoxycholate, 5 mM
EGTA, 2 mM MgCl2 in PBS. Heads were equilibrated in
30% sucrose/PBS and sectioned (15 Am) on a cryostat.
Sections were rinsed several times in wash buffer (2 mM
MgCl2, 0.02% NP40, 0.01% sodium deoxycholate in PBS),
transferred to staining solution (wash buffer supplemented
with 5 mM potassium ferricyanide, 5 mM potassium
ferrocyanide, and 1 mg/ml X-gal), and stained overnight
at 37-C in darkness. Staining was stopped with 20 mM
EDTA in PBS and sections were counterstained with
Nuclear Fast Red.
Whole mount TUNEL
Whole mount terminal deoxynucleotidyl nick end label-
ing (TUNEL) was performed according to a published
protocol (Smith and Cartwright, 1997) using the ApopTag
in situ apoptosis detection kit (Chemicon International).
TUNEL-labeled embryos were either photographed or
visualized by optical projection tomography (OPT) accor-
ding to Sharpe et al. (2002).
Whole mount in situ hybridization
Whole mount in situ hybridization was carried out as
described by Xu and Wilkinson (1998) with digoxigenin-
labeled riboprobes for Fgf 8 (Crossley and Martin, 1995),
Nkx2.1 (Shimamura et al., 1995), and Wnt8b (Richardson
et al., 1999).Results
Calculation of cell cycle kinetics
Since the telencephalon of mice lacking Foxg1 is
severely hypoplastic (Xuan et al., 1995), we examined
whether the cell cycle time (Tc) of telencephalic progen-
itors is misregulated during the neurogenetic interval. To
achieve accurate estimates of Tc, a bromodeoxyuridine/
iododeoxyuridine (BrdU/IddU) double labeling paradigm
(Shibui et al., 1989) was adapted and optimized to measure
cell cycle kinetic parameters in the developing tele-
ncephalon in vivo. This technique allows the estimation
of Tc and the duration of S-phase (Ts) in a single specimen
(see Materials and methods).
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reliable, and can be used to estimate parameters in defined
groups of cycling cells in individual embryos. Estimates of
cell cycle parameters in wild-type embryos generated in this
study are very similar to those obtained at a range of ages by
various authors using the more traditional technique of
BrdU cumulative labeling (Bhide, 1996; Estivill-Torrus et
al., 2002; Takahashi et al., 1995a,b; Yuasa et al., 2002) (Fig.
1F). The correlation between the wild-type values of Tc
obtained here and those previously published at comparable
ages is statistically significant (P = 0.022, Pearson
correlation test, n = 9).
Cell cycle time increases precociously in the Foxg1/
telencephalon
Cell cycle kinetics of telencephalic progenitor cells were
estimated at several ages during early and mid-neurogenesis
in control (wild-type and Foxg1+/ heterozygotes, see
Materials and methods) and Foxg1/ embryos (Fig. 2).
Numerous counts were made in sampling bins throughout
the telencephalon at E9.5, E10.5, and E11.5, and in the
dorsal telencephalon at E14.5, to give an average estimate ofFig. 2. Cell cycle times increase precociously in the Foxg1/ tele-
ncephalon. Patterns of IddU and BrdU labeling within the ventricular zone
are very similar in (A) wild-type and (B) Foxg1/ telencephalon at E10.5,
suggesting that inter-kinetic nuclear migration and the general mechanics of
precursor cell division are not severely perturbed in the mutant. The
presence of non-IddU-labeled mitotic figures (asterisks) shows that Ti < the
length of G2 and M-phases (TG2+M). These facts suggest that it is
appropriate to apply the IddU/BrdU labeling technique to control and
experimental embryos. (C) Mean Tc increases with developmental age in
both control and Foxg1/ telencephalon, but the trend is accelerated in
mutant embryos, as shown by linear regressions. The difference in Tc
between control and mutant telencephalon over developmental time is
significant (P = 0.002, analysis of variance by general linear model, n = 12
embryos). (D) Histogram showing mean Ts T SD at a range of ages in
Foxg1/ embryos (open bars) and control embryos (filled bars). Ts
remains relatively constant at 4–5 h in both wild-type and mutant at all
ages analyzed, except at E14.5 when Ts is longer in the Foxg1
/ dorsal
telencephalon.Tc for each embryo at each age. Patterns of IddU and BrdU
labeling were very similar in control (Fig. 2A) and mutant
sections (Fig. 2B). Cells in S-phase are BrdU labeled (red)
and, as expected, were found in the outer half of the
ventricular zone. Cells which had left S-phase during the
labeling period (IddU-labeled only, green) had moved
towards the ventricular surface. The presence of unlabelled
mitotic figures (asterisks in Figs. 2A and B) shows that Ti is
shorter than the length of G2 and M-phases (TG2+M) so the
number of cells in the Lcells fraction is not artificially
inflated by the counting of recently divided cells. These
findings suggest that interkinetic nuclear migration and the
general mode of telencephalic precursor proliferation are not
severely affected by the loss of Foxg1. Fig. 2C shows that at
E9.5 mean Tc is approximately 7 h in control and Foxg1
/
telencephalon. Around E10.5, neurogenesis commences and
the first post-mitotic neurons appear at the pial surface of the
telencephalic neuroepithelium. As neurogenesis proceeds,
there is a gradual lengthening of Tc with age in both control
and Foxg1/ telencephalon (Fig. 2C). This slowing of
progenitor proliferation rate is more severe and occurs
earlier in the Foxg1/ telencephalon. At E14.5, the mid-
point of wild-type neurogenesis, when cell output should be
at its peak (Caviness et al., 1995; Takahashi et al., 1996), the
mean cell cycle time of Foxg1/ dorsal telencephalic
precursors is more than twice that of their wild-type
counterparts (29 h and 14 h, respectively). The difference
in Tc between control and mutant observed over time is
statistically significant (P = 0.002, univariate general linear
model, n = 12).
Interestingly, the length of S-phase is very similar in
wild-type and mutant precursors, averaging between 4 and 5
h (very similar to wild-type Ts measured by other authors;
Bhide, 1996; Estivill-Torrus et al., 2002; Takahashi et al.,
1995a,b) at all ages except E14.5, where it is lengthened as
the mutant cell cycle becomes more disregulated (Fig. 2D).
These results suggest that while the mode of progenitor
cell division is not grossly altered in the Foxg1/
telencephalon, there is an early and significant reduction
in proliferation rate from E10.5, co-incident with the start of
neurogenesis. From this age onwards, the mutant telence-
phalon is notably reduced in size (Xuan et al., 1995; and this
study). This reduction in proliferation rate is very likely to
contribute to the observed hypoplasia.
Cell cycle time is altered in a region-specific fashion
At E9.5, the Foxg1/ telencephalon is similar in size to
wild-type controls. However, as development proceeds, the
mutant telencephalon appears to grow more slowly than
wild-type telencephalon. At E12.5, the telencephalon of
Foxg1/ embryos is clearly hypoplastic relative to that of
controls and this is more apparent rostrally than caudally
(Fig. 3, compare A and C with B and D, and E and G with F
and H). Morphologically there is also a loss of ventral
telencephalic structures. The ganglionic eminences, which
Fig. 3. Morphological abnormalities of the Foxg1/ telencephalon. At
E12.5, the mutant telencephalon is notably reduced in size relative to
control and ventral ganglionic eminences are notably absent. LacZ reporter
activity from the Foxg1lacZ locus marks the telencephalic territory in
Foxg1+/ and Foxg1/ tissue sections in the coronal plane. The size
reduction is more pronounced in rostral regions (compare A and C with B
and D) than in caudal sections (compare E and G with F and H). ge,
ganglionic eminences.
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(Figs. 3C and E), fail to form in the absence of Foxg1 (Figs.
3D and F). Previous studies have also failed to detect
genetic markers of ventral telencephalic fate at E10.5 and
E12.5 (Dou et al., 1999; Xuan et al., 1995).
We used IddU/BrdU labeling to determine whether the
reductions in rostral and ventral telencephalic tissues arerelated to region-specific variations in the rate of cell cycle
progression. To achieve this, the telencephalon was systema-
tically divided into sampling bins across the full dorso-ventral
and rostrocaudal axes (Fig. 4A). Tc was determined in each
bin in several control and Foxg1/ embryos at E9.5, E10.5,
and E11.5. The results were plotted relative to position and
graphs were consistent between each genotype and at each
age; representative examples are shown in Figs 4B–G. At
E9.5, when there is no overall difference in mean Tc between
the mutant and wild-type (Fig. 2C), the Tc values obtained
were fairly constant across the whole telencephalon in
embryos of both genotypes (Figs. 4B and C). At E10.5,
when loss of Foxg1 causes an increase in the mean Tc (Fig.
2C), the defect was not observed throughout the telence-
phalon, but is region-specific. Consistently, cells in rostral
and dorsal territories have an increased Tc, while cells in
caudal and ventral regions continue to progress through the
cell cycle at a rate comparable to control littermates (Figs. 4D
and E). This rostral defect is even more pronounced at E11.5
and at this stage, groups of more slowly proliferating cells
appear in more caudal regions (Figs. 4F and G).
At E14.5, Tc and Ts were estimated in three equally
spaced domains along the rostrocaudal axis (Fig. 4H) in a
single 200-Am-wide sampling bin in the dorsal telencepha-
lon of control (Fig. 4J) and mutant (Fig. 4K) embryos. Tc
was significantly increased (Student’s t test, P < 0.05, n = 3)
at all three rostrocaudal levels, with a particularly large
increase rostrally, where mutant Tc is three times that of
control, as shown in Fig. 4I.
Our finding that cell cycle time was not increased in
ventral regions of the Foxg1/ telencephalon at E10.5
contrasts with the previous suggestion that proliferation rate
is reduced in this territory in this mutant (Xuan et al., 1995).
This finding was based on calculation of the proportion of
cells which had incorporated BrdU following pulse labeling
with the halogenated pyrimidine. We do not see a difference
in BrdU labeling index (LI, the percentage of VZ cells
labeled with BrdU) in the ventralmost region of Foxg1/
and control embryo telencephalon at E10.5 (see Fig. 5). LI
is 56.7 T 8.3% in control and 54.6 T 3.1% in Foxg1/
ventral telencephalon (n = 3).
The ventral telencephalon is never specified in the Foxg1/
telencephalon
Cell cycle time was never consistently increased in
ventral regions of the Foxg1/ telencephalon. Consequen-
tly, it seems very unlikely that a reduction in proliferation
rate causes the lack of ventral telencephalic structures and
marker gene expression later in development. We therefore
examined the expression of regionally restricted marker
genes from early stages of telencephalic development to
establish whether the ventral telencephalon is ever specified
in the absence of Foxg1.
At E8.5, prior to the closure of the anterior neural tube,
the prosencephalic neural plate is patterned into distinct
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expression marks prospective ventral diencephalon (cau-
dally) and ventral telencephalon (rostrally). In Foxg1/
embryos at this age, the expression of Nkx2.1 does not
extend rostrally into the prospective telencephalon (arrowsFig. 5. BrdU labeling in ventralmost telencephalon. (A and B) Low power
images of comparable coronal telencephalic sections from wt and Foxg1/
embryos. (C and D) Higher power images of boxed areas in A and B
showing cells labeled with BrdU following a 30-min pulse of BrdU (red).
Nuclei are counterstained with TO-PRO-3.in Figs. 6A and B), consistent with a failure to induce the
ventral telencephalon. At E9.5, there is a total absence of
Nkx2.1 expression in the ventral region of the Foxg1/
telencephalon (Fig. 6D), but not in the ventral diencephalon
(Fig. 6H). At E9.5, Mash1, which appears in the ventralmost
telencephalon of normal embryos at this age (Fig. 6E), is
also absent from the Foxg1/ telencephalon (Fig. 6F) but
is still present in the dorsal and ventral diencephalon (Fig.
6G). By E10.5, Gsh2 gene expression becomes detectable inFig. 4. Cell cycle time is increased in a region-specific fashion in Foxg1/
mutants. Tc and Ts were estimated in sampling bins covering the whole of
the developing telencephalon at E9.5, E10.5, and E11.5 as schematized in
A. Approximately every 6–10th section was imaged. The section was
divided into 100-Am-wide sectors and cell counts were made through the
depth of the telencephalic wall from the dorsal to ventralmost extent of the
telencephalon in alternate sectors (the coronal section shown in A is taken
from level marked by asterisks in the lateral view). This allowed the
mapping of Tc values measured at evenly spaced interval across the surface
of the telencephalon. (B–G) 3D plots from representative embryos at the
three ages analyzed. (B and C) At E9.5, Tc was constant across the
telencephalon in control and mutant telencephalon. (D and E) By E10.5,
populations of cells in rostral and dorsal portions of the Foxg1/ had
inflated Tc’s relative to control. (F and G) At E11.5, lengthening of Tc was
more severe and was observed through much of the mutant telencephalon.
(H) At E14.5, groups of three non-adjacent sections in caudal, rostral, and
medial positions were analyzed. (J and K) Cell cycle analysis was
conducted in a 200-Am counting bin placed in a dorso-lateral position of
the neocortex in mutant and control sections. (I) At all three rostrocaudal
levels, Tc was significantly higher in the Foxg1
/ dorsal telencephalon
(open bars) than in controls (filled bars) ( P < 0.05, Student’s t test, n = 3).
Histogram shows mean Tc T SD. tel, telencephalon; di, diencephalon; oe,
optic eminence; mes, mesencephalon.
Fig. 6. Ventral telencephalon is not specified in Foxg1/ mutants. (A and B) Whole mount in situ hybridization for Nkx2.1 in control and mutant embryos at
E8.5 shows reduced anterior expression of Nkx2.1 (compare arrows in A and B), consistent with loss of ventral telencephalic induction. Dotted line marks
approximate di/telencephalic boundary. (C and D) Nkx2.1 immunohistochemistry shows total absence of expression in Foxg1/ telencephalon at E9.5. (E and
F) Immunohistochemistry shows first appearance of Mash1 expressing cells in wild-type ventral telencephalon (arrow in E), but not in the mutant. (G and H)
Foxg1/ diencephalon appears correctly patterned with Mash1 expression in dorsal and ventral domains (Asterisks in G) and Nkx2.1 protein ventrally (H). (I
and J) By E10.5, Gsh2 is detectable in control, but not Foxg1/ ventrolateral telencephalon. (K, L, M, and N) Pax3 expression in the dorsalmost telencephalic
cells is slightly increased in Foxg1/ embryos at E9.5 and E10.5 (asterisks in M and N), consistent with an expansion of dorsal fates. (O and P) Pax6 is
expressed from the most dorsal to ventral telencephalon in Foxg1/ mutants (red arrow marks ventralmost telencephalon, which is fused directly with
developing eye). d.tel., dorsal telencephalon; v.tel, ventral telencephalon; di, diencephalon; oe, optic eminence. All sections are in the coronal plane, except for
O and P, which are sagittal.
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which will later give rise to the lateral ganglionic eminence
(LGE) (Corbin et al., 2000, 2003). Gsh2 expression iscompletely absent from the Foxg1/ telencephalon (Fig.
6J). In agreement with previous authors (Dou et al., 1999;
Xuan et al., 1995), we fail to see expression of ventral
Fig. 7. Apoptosis is reduced in the rostral telencephalic midline of Foxg1/
mutants. (A and B) Whole mount TUNEL shows that apoptotic cells are
present in the rostral midline of the wild-type (arrowhead in A) and
Foxg1/ telencephalon (arrowhead in B) at E9.5. At E10.5, TUNEL-
labeled cells are still observed in the rostral telencephalon of controls
(arrows in C, E) but almost completely absent in the Foxg1 mutant (arrows
in D and F). Some TUNEL-labeled embryos were scanned with optical
projection tomography (OPT) allowing for the digital reconstruction of the
complete set of optical sections for each embryo, which provided
verification that this rostral apoptotic population is in the neuroepithelium,
rather than the overlying surface epithelium. Examples of pseudo-colored
optical sections are shown in E and F with regions of TUNEL-labeling in
red.
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the Foxg1/ telencephalon later in development (at E12.5),
demonstrating that ventral specification is not simply
delayed (data not shown). Concurrent with the loss of
ventral marker gene expression, dorsal cell types are over-
represented when Foxg1 is absent. Pax3, which marks the
dorsalmost of telencephalic cells (Fig. 6K), is expressed in a
slightly expanded dorsal zone in Foxg1/ telencephalon
and appears ectopically in a number of laterally and
ventrally positioned cells at E9.5 (Fig. 6L). At E10.5, the
roofplate Pax3 domain is clearly expanded in Foxg1
mutants relative to control, while the ectopic lateral and
ventral expression seen at E9.5 is no longer apparent (Figs.
6M and N). Pax6, whose expression is normally restricted to
the dorsal telencephalon (Fig. 6O), is expanded throughout
the whole of the Foxg1/ telencephalon at E9.5, E10.5,
and E11.5 (Fig. 6P and data not shown).
The gene expression studies described here provide
good support for the idea that Foxg1 is required for the
induction of the ventral telencephalon, and in the absence
of this transcription factor, dorsal telencephalic fates are
expanded.
Apoptosis is reduced in the rostral telencephalon of
Foxg1/ mutants
As well as the reduced precursor proliferation rate
measured here, it is possible that an increase in the level of
programmed cell death contributes to the morphological
abnormalities and hypoplasia of the Foxg1/ telencepha-
lon. To examine levels of apoptosis in the developing
telencephalon, whole-mount TUNEL was performed on
Foxg1/ embryos and wild-type littermates. At E9.5,
TUNEL-labeled cells in the telencephalon are restricted to
the dorso-rostral midline (Aoto et al., 2002; Furuta et al.,
1997; Ohkubo et al., 2002) (Figs. 7A and B). At this age,
although it appears that there may be slightly fewer labeled
cells in Foxg1/ telencephalon, this was not consistent (n =
3 per genotype). A day later, at E10.5, there is a clear and
consistent reduction in the number of TUNEL labeled cells
in this rostral domain in the Foxg1 mutant telencephalon at
E10.5 in all embryos analyzed (n = 3) (compare Figs. 7C and
E with D and F and Supplementary movie 1 with movie 2).
Scanning TUNEL-labeled embryos with optical projection
tomography (OPT) (Sharpe et al., 2002) showed that
apoptotic cells are in the telencephalic neuroepithelium,
rather than the overlying ectoderm. Few apoptotic cells were
observed in ventral regions of Foxg1 mutant or control
embryos, and as such, increased cell death does not seem to
contribute to the impaired development of the Foxg1/
ventral telencephalon. Patterns of apoptosis in non-tele-
ncephalic parts of Foxg1/ embryos are otherwise indis-
tinguishable from those in wild-types, with labeled cells in
the midline of the diencephalon and mesencephalon, in the
facial ectoderm, somites, and limb buds (Supplementary
movies 1 and 2), suggesting that the observed decrease inTUNEL-labeled cells in the telencephalon results specifi-
cally from the loss of Foxg1.
Neurogenesis is accelerated in the Foxg1/ telencephalon
In addition to the regulation of proliferation rate and
the rate of cell death, the rate at which the progeny of
neurogenic cell divisions withdraws from the cell cycle to
differentiate must be tightly controlled to ensure neurons
are produced in correct numbers at the correct time.
Previous authors have observed an early accumulation of
cells expressing markers of post-mitotic neurons in the
mantle zone of the Foxg1/ telencephalon from E12.5
onwards (Hanashima et al., 2002; Xuan et al., 1995).
Here, these observations are confirmed and extended to
show that an excess of neurons is produced from E11.5
onwards.
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the depth of the telencephalic wall was counted systematically
in several rostral and caudal sections throughout the dorso-
ventral extent of the telencephalon in Foxg1/ embryos and
in the control dorsal telencephalon (the neocortex). Sections
used were taken from an embryo that had been labeled with a
short pulse (30 min) of BrdU, which revealed the position of
S-phase nuclei. These lie at the outside edge of the ventricular
zone (Takahashi et al., 1992). Cell nuclei superficial to the S-Fig. 8. Neurogenesis is accelerated in the absence of Foxg1. (A, B, C, and
D) In Foxg1/ and control telencephalon, post-mitotic neurons (h-III-
Tubulin positive, green) are found exclusively in the mantle zone (mz),
superficial to the ventricular zone (vz), the outer edge of which is defined
by cells labeled by a 30-min pulse of BrdU (red). At both E11.5 (A and B)
and E14.5 (C and D), the mutant mz appears thicker, relative to the vz. (E)
Cells in the mantle zone (MZ) were counted to assess the average number
of differentiated cells at E11.5. Counts were made in sampling bins in the
dorsal telencephalon in groups of rostral and caudal sections. Mean number
(TSD) of cells outside the VZ in control (filled bars) and Foxg1/ (open
bars) telencephalon are plotted. In both rostral and caudal regions, the
number of differentiated cells in the mutant dorsal telencephalon is
significantly greater than control (P < 0.05, Student’s t test, n = 3–4).
di, diencephalon; d. tel, dorsal telencephalon; v. tel, ventral telencephalon.phase zone were considered post-mitotic and counted as such.
This was confirmed by double labeling with h-III-Tubulin, an
early marker of differentiating neurons, in control and
Foxg1/ telencephalons (Figs. 8A and B). In both control
and mutant embryos, very few cells expressing this neuronal
marker were observed within the ventricular zone (see
Supplementary Figs. 1I and J). The average numbers of cells
in the sampling bin positioned superficial to the ventricular
zone averaged across several rostral and caudal sections for
3–4 embryos per genotype are plotted in Fig. 8E.
In both rostral and caudal telencephalon, the number of
cells outside the ventricular zone is two to three times larger
in Foxg1/ embryos than in their normal littermates. These
differences are statistically significant (P < 0.05, Student’s t
test, n = 3–4). The early exit of precursor cells from the cell
cycle must limit the proliferative potential of the mutant
telencephalon and contributes to its serious growth defects.
Indeed, by E14.5, the mantle zone in Foxg1 mutants is
much wider than in the control dorsal telencephalon and
whole hemisphere is clearly smaller (Figs. 8C and D). In
contrast to the proliferative and apoptotic defects described
earlier, we saw no significant difference in the number of
post-mitotic neurons in rostral and caudal regions of the
mutant telencephalon.
Fibroblast growth factor 8 expression is greatly reduced in
the Foxg1/ rostral telencephalon
Members of the Fibroblast growth factor (Fgf) family
have been shown to have numerous roles in the develop-
ment of various structures in developing embryos,
including the telencephalon. Fgf 8 seems to be a
particularly important morphogenetic cue for the develop-
ment of the telencephalon. In the wild-type, Fgf 8 is
expressed in a discrete pattern at the rostral pole of the
telencephalon from its initial specification (¨E8) until at
least E12.5 (Crossley and Martin, 1995; Crossley et al.,
2001; Shimamura and Rubenstein, 1997). Gain and loss
of function studies have demonstrated that Fgf 8 is
important for controlling rostrocaudal patterning of the
telencephalon (Fukuchi-Shimogori and Grove, 2001) and
also for regulating cell proliferation (Lee et al., 1997;
Martinez et al., 1999) and survival (Storm et al., 2003).
Given its role as a potent controller of telencephalic
morphogenesis, the pattern of Fgf 8 expression was
examined in control and Foxg1/ mutant embryos. At
E9.5, before proliferative, apoptotic, and differentiative
defects are observed, Fgf 8 expression is detectable in the
rostral telencephalon of Foxg1/ embryos and controls
(n = 3 per genotype), although expression levels may be
slightly lower overall and the rostro-ventral limit of
expression may be shifted in the mutant telencephalon
(Figs. 9A and B). At E10.5, there is a striking reduction
in the level of Fgf 8 expression in the anterior tele-
ncephalon of Foxg1 mutant embryos relative to controls
(n = 3 per genotype) (Figs. 9C and D).
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at this age, the reduction in Fgf8 expression is not due to
programmed cell death of expressing cells. The reduced
proliferation rate described above, although it is first
observed in the same rostrodorsal domain that expresses
Fgf 8, also seems an unlikely cause since it coincides with,
rather than precedes, the reduction in expression. Previous
researchers have shown that BMP4, 6, and 7, which are
normally restricted to the dorsomedial wall of the tele-ncephalon, are expanded in the Foxg1/ telencephalon
after E11.5 (Dou et al., 1999; Hanashima et al., 2002).
Furthermore, it has been shown that enhanced BMP
signaling can repress Fgf8 expression in the chick tele-
ncephalon (Ohkubo et al., 2002). To examine whether
excess BMP signaling might contribute to the loss of Fgf 8
expression described above, we examined expression of
direct effectors of BMP signaling: tyrosine phosphorylated
forms of Smad-1,5,8 (P-Smad). At E10.5, immunohisto-
chemistry for P-smad revealed positive nuclei around the
ventricular surface of the telencephalic neuroepithelium and
a slightly increased level of staining in the roofplate region
of the telencephalon, where BMP expression has been
documented (Furuta et al., 1997). There is no clear
difference in P-smad staining in control and Foxg1/
telencephalon at E10.5 (Figs. 9E and F). A day later,
however, at E11.5 when BMP expansions have been
demonstrated (Dou et al., 1999, Hanashima et al., 2002),
increased P-smad staining is observed in the Foxg1/
telencephalon, especially in dorsomedial regions (Figs. 9G
and H).
It is also possible that changes in other dorsally restricted
signaling molecules, such as the Wnt proteins, may alter
Fgf 8 expression in Foxg1/ mutants. We therefore
examined the expression of Wnt8b at E10.5. In both control
and mutant embryos, Wnt8b mRNA was restricted to the
dorsomedial telencephalic wall (Figs. 9I and J).
These data suggest that BMP and Wnt signalling activity
are present and correctly localized in the Foxg1/ tele-
ncephalon at E10.5. However, since they are not expanded
at the time that Fgf 8 expression is reduced (E10.5), it seems
unlikely that increases in these dorsally derived signals
cause this repression directly.Discussion
During the neurogenetic interval of telencephalic deve-
lopment (¨E10.5–E17.5 in mouse, Caviness et al., 1995;Fig. 9. Fgf8, BMP, and Wnt signalling pathways in control and Foxg1/
telencephalon. (A and B) Whole mount in situ hybridization at E9.5 for
Fgf8 shows this signalling molecule is expressed in the rostral tele-
ncephalon of both Foxg1/ and wild-type embryos, although it may be
slightly reduced and does not extend so far ventrally in the mutant (arrow in
B). (C and D) At E10.5, there is dramatic reduction in the level of Fgf8
expression in the same rostral telencephalic domain in Foxg1 / embryos
(arrows). At both ages, Fgf8 expression in other structures, notably the
branchial arches (br), nasal pits (np), and isthmus (is), is not affected by the
loss of Foxg1. (E, F, G, and H) Immunohistochemistry on coronal sections
for phosphorylated Smad-1,5,8 (P-smad), a readout of BMP signalling. At
E10.5, there is no clear difference in P-smad staining between mutant and
control, with positive cells around the ventricular surface and increased
staining in the medial telencephalon (asterisks in E and F). By E11.5, there
is increased P-smad staining in the null telencephalon, particularly in the
medial telencephalon (arrow in H). (I and J) Whole mount in situ
hybridization for Wnt8b shows that this Wnt family member is expressed
appropriately in a restricted dorsomedial band of control and mutant
telencephalon (white arrows).
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very tightly regulated. This is necessary to allow the
orchestrated production of the correct type of neurons, in
the right place, at the right time. Even relatively small
alterations in cell cycle time can have significant effects on
cellular output from the proliferative zone. Dehay et al.
(1993) and Polleux et al. (1997) describe how region-
specific regulation of cell cycle kinetics within the
proliferative zone during development is used to generate
the unique structure of different neocortical areas in the
adult mammal. Our results indicate that the transcription
factor Foxg1 contributes to the development of the
telencephalon by maintaining telencephalic progenitor
status and ensuring that these progenitors maintain
appropriate cell cycle kinetics, particularly in the rostral
telencephalon.
Here, a technique developed to study proliferation
kinetics of tumor cells in vitro (Shibui et al., 1989) and in
vivo (Miller et al., 1991) has been adapted and optimized for
kinetic studies of proliferating populations in the developing
embryo. The use of two halogenated pyrimidines, BrdU and
IddU, which are incorporated into actively synthesizing
DNA with very similar kinetics (Yousuf et al., 1991),
provides a rapid and accurate means of measuring the Tc and
Ts of a proliferating population. Unlike the traditional
method of BrdU cumulative labeling (Nowakowski et al.,
1989), this technique has the key advantage that these
factors can be estimated in a single specimen. This is
achieved without the sacrifice of accuracy. Results gene-
rated here in wild-type embryos are very similar to those
obtained by the cumulative labeling technique. The new
technique was used to provide a thorough analysis of the
proliferation kinetics in the telencephalon of mouse mutants
lacking the transcription factor Foxg1.
Previous authors have demonstrated that patterns of
BrdU labeling are altered in the telencephalon of Foxg1/
embryos, especially in rostral and ventral regions (Xuan
et al., 1995), and inferred that cell cycle time is increased
after E11.5 (Hanashima et al., 2002). We have used IddU/
BrdU labeling to provide cell cycle kinetic estimates in
Foxg1 mutants to show that cell cycle time is increased in
rostral and dorsal portions of the telencephalon at E10.5,
and that these defects spread through the neuroepithelium
as neurogenesis proceeds. Reduced proliferation rate must
be a primary causal factor for the reduced size and cell
number in the Foxg1/ telencephalon observed from
mid-gestation until the perinatal death of these embryos
(Xuan et al., 1995).
Interestingly, the earlier study of BrdU labeling indices in
the Foxg1 mutant found that fewer cells in the ventral
region of the telencephalon took up BrdU than their wild-
type counterparts at E10.5 (Xuan et al., 1995). This
evidence was used to infer that proliferation rate was
specifically reduced in this region and, by extension, was
responsible for the loss of ventral telencephalic tissue, as
assessed by genetic markers, observed at later ages (Xuan etal., 1995; and this study). We found no evidence for reduced
proliferation rate in the ventral portion of the mutant
telencephalon, but concur that markers normally associated
with the ventral telencephalon are indeed lost. Instead of
reduced precursor proliferation or increased apoptosis
leading to disproportionate loss of pre-specified ventral
telencephalic tissue, we favor the hypothesis that the ventral
telencephalon is never actually specified in the absence of
Foxg1, in line with the failure to detect any ventral gene
expression even at very early stages of telencephalic
development. The different conclusions from our study
and that of Xuan et al. (1995) do not appear to be due to the
different approaches used to assess proliferation rates. We
found no difference in BrdU labeling index in ventralmost
telencephalon between Foxg1/ and control telencephalon
(Xuan et al., 1995). It is not clear why such a difference is
observed. It may, at least in part, be explained by subtle
methodological differences and differences in genetic back-
ground between the embryos we analyzed and those of
Xuan et al. (1995).
What then is the requirement for Foxg1 in the induction
of ventral telencephalic cell fates? Numerous lines of
evidence suggest that Sonic Hedgehog (Shh) signalling is
necessary and sufficient for ventral telencephalic patterning
(reviewed in Zaki et al., in press). A previous study (Huh
et al., 1999) demonstrated that Shh is not expressed in the
Foxg1/ mutant ventral telencephalon. However, since
markers of ventral telencephalon appear before Shh is
expressed in the ventral telencephalon itself (Shimamura
and Rubenstein, 1997), it has been proposed that Shh from
non-telencephalic sources, or some other as yet unidentified
factor, must initially induce ventral fate in the telencephalon.
Perhaps these extra-telencephalic Shh sources are absent in
the Foxg1 mutant, or perhaps Foxg1 is required cell
autonomously in telencephalic cells to take on ventral fate
in response to ventralizing signals.
In addition to a reduced proliferation rate in the rostral
telencephalon at the onset of neurogenesis, the rate of
apoptosis is misregulated in Foxg1/ embryos. Contrary to
the notion that increased apoptosis could be contributing to
the hypo-cellularity of the mutant telencephalon, fewer
apoptotic cells are observed in the rostral midline at E10.5.
Interestingly, the reduction in apoptosis observed here is
somewhat at odds with the results of Ahlgren et al. (2003),
which suggested that Foxg1 acts primarily to suppress
apoptosis. However, this study focussed on the chick neural
tube, where the gene may have a rather different mode of
action, and was based on retroviral over-expression of
Foxg1. Despite these differences, we cannot rule out the
possibility that in particular contexts Foxg1 may act to
suppress neural apoptosis.
The defects of cell proliferation and apoptosis, which
begin in the rostral telencephalon at E10.5, may be directly
related to the reduction in expression of the potent
morphogen Fgf8 in this territory. Members of the Fgf
family are often mitogenic in activity. Indeed, several
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cellular proliferation in a variety of tissues in the developing
embryo. It is expressed in several major outgrowths of the
embryo during their rapid expansion: the rostral tele-
ncephalon; the apical ectodermal ridge of the limb bud;
and the developing tailbud (Crossley and Martin, 1995).
More direct experimental evidence that FGF8 is pro-
proliferative in the developing central nervous system
comes from experiments involving ectopic application of
the protein to the midbrain and diencephalon (Martinez et
al., 1999) and its transgenic misexpression in the mesen-
cephalon (Lee et al., 1997). Both of these manipulations
caused dramatic overgrowth of the midbrain and caudal
forebrain. We know of no previous studies which have
directly related telencephalic FGF8 to proliferation rate.
However, correlative evidence presented here suggests that
FGF8 may have a similar pro-proliferative role in the most
anterior brain structure. Reduced FGF8 levels may contri-
bute to the reduced precursor proliferation rate observed in
the rostral telencephalon of the Foxg1 mutant.
While FGF8 level may have a direct relationship with
proliferation rate, the relationship to cell survival does not
seem to be so straightforward. High levels of apoptosis are
seen in the same terminal outgrowths listed above, which
express high levels of FGF8 and are proliferating rapidly,
perhaps suggesting that very high exposure to FGF8 can
promote programmed cell death. A recent paper suggested
that such a paradoxical relationship is observed between
FGF8 dosage and cell survival (Storm et al., 2003).
Increasing or eliminating FGF8 caused increased apoptosis
in telencephalic explants, while a hypomorphic allele that
produces lower levels of FGF8 led to enhanced survival.
The result presented here is directly comparable to this
finding. At E10.5, when Fgf8 expression is greatly reduced,
but not totally eliminated in the Foxg1 mutant, an enhance-
ment of cell survival is seen.
It is very interesting to consider why Fgf 8 expression is
lost from the Foxg1/ telencephalon. One possibility is
that it is a consequence, rather than a cause, of the reduced
rostrodorsal proliferative defects described here. However,
this seems an unlikely explanation for two reasons. Firstly,
while the reduction in Fgf 8 is spatially correlated with
reduced proliferation rate, it is also temporally coincident.
Reduced proliferation would have to precede the Fgf 8
reduction to explain it. Secondly, the reduced cell death
observed in the same area that expresses Fgf 8 would be
predicted to cause an expansion, rather than a contraction of
the number of cells expressing this factor. A more likely
reason for the loss of Fgf 8 may be the absence of the potent
ventrally derived signalling molecule Sonic Hedgehog
(Shh) from the Foxg1/ telencephalon (Huh et al.,
1999). In Shh/ embryos, just like in the Foxg1/
embryos, Fgf 8 is induced but not maintained, although in
the former Fgf 8 expression is lost somewhat earlier, at E9
(Ohkubo et al., 2002). It is also possible that Foxg1 may
have a more direct effect on the Fgf 8 promoter itself and isperhaps required for the maintenance, if not the induction,
of telencephalic Fgf8 transcription after E9.5.
In this paper, we also provide evidence that cell fate
choice is misregulated during neurogenesis in Foxg1/
embryos. While neuron production at E10.5 appears similar
to wild-type (Hanashima et al., 2004; and data not shown),
at E11.5 the number of post-mitotic neurons in the mantle
zone of the mutant is significantly greater than that of
controls. This finding suggests that either the neurogenic
program is ectopically activated in precursors without cell
division or that there is an increase rate of neurogenic
divisions (either symmetrical or asymmetrical) in the
Foxg1/ telencephalon at this early stage of neurogenesis.
This early depletion of the proliferative population com-
bines with decreased proliferation rates of the remaining
precursors to drastically limit the growth of the Foxg1/
telencephalon.
While the slowing in proliferation rate and reduction in
apoptosis are focussed specifically in rostrodorsal areas, the
defects in the early differentiation rate do not share this
spatial pattern. Instead, the early appearance of post-mitotic
neurons occurs at all levels of the telencephalon. Given that
FGF8 dosage has not been linked to neuronal differ-
entiation rate and that the observed cell fate defect is more
diffusely located, we find it unlikely that the reduction in
Fgf8 expression described here contributes to this aspect of
the mutant phenotype. One possibility here is that the
increased rate of neuronal differentiation is caused by the
increased expression of Bmps 2, 4, 6, and 7 whose
expression expands beyond their normal dorsal midline
domain (Furuta et al., 1997) to fill much of the tele-
ncephalic neuroepithelium of Foxg1/ embryos at E11.5
(Dou et al., 1999; Hanashima et al., 2002). Various studies
in vivo and in vitro suggest that Bmps can increase the
differentiation rate of telencephalic neuronal precursors (Li
et al., 1998; Mehler et al., 2000). Consistent with this
hypothesis, when Foxg1 is replaced by a DNA-binding
defective form of the gene, the proliferative defects in the
dorsal telencephalon seem to be rescued, while the early
differentiation and, importantly, expanded Bmp expression
are not (Hanashima et al., 2002). This does suggest that
excess Bmp can induce neuronal differentiation, but may
not influence precursor proliferation kinetics, at least at the
developmental stage studied. Foxg1 may therefore be
required to repress BMP expression outside of the cortical
hem and protect the telencephalon from this powerful
differentiative signal. It has also been suggested that Foxg1
is required cell-autonomously to repress production of the
earliest born telencephalic neurons, Cajal–Retzius cells,
which are produced in excess in Foxg1/ mutant mice
(Hanashima et al., 2004). Another recent study suggested
that Foxg1 is required within the telencephalon to suppress
the cytostatic action of Transforming Growth Factor h
(TGFh) (Seoane et al., 2004).
In summary, these findings emphasize the position of
Foxg1 as a key regulator of several aspects of the
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lack of specification of the ventral telencephalon. Later, as
neurogenesis commences, reduced proliferation rate,
increased differentiation rate, and a localized decrease in
the level of apoptosis are observed in the Foxg1/
telencephalon. Foxg1 may regulate these different processes
by distinct mechanisms. The data are consistent with a
model whereby Foxg1 regulates, directly or indirectly, the
expression of a range of morphogenetic molecules in the
developing telencephalon. The early loss of telencephalic
Shh (Huh et al., 1999) may be at the head of a cascade of
defects in the expression of telencephalic signalling
molecules. According to this model, Foxg1 is required
for the induction of Shh in the ventral telencephalon. In
the absence of Shh, Fgf8 expression cannot be maintained
after E9.5–E10. Falling FGF8 levels may explain the
proliferative and apoptotic defects, which begin at E10.5.
Since Fgf8 has recently been shown to repress Wnt and
BMP signalling from the dorsal telencephalon (Shimogori
et al., 2004), loss of Fgf8 may then allow the expression
of these molecules to expand through the telencephalon
after E10.5. This expansion, of BMP in particular, may
drive the increased neuronal differentiation observed later
in the Foxg1/ telencephalon. The sequential accumu-
lations of the developmental defects described here correlate
with these changes in expression of signalling molecules
and support such a cascading model of increasingly
perturbed telencephalic development and place Foxg1 in
an important position as a molecule responsible for
maintaining the balance between the activity of multiple
signalling pathways.Acknowledgments
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